查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1726160

藥物傳輸市場規模、佔有率、趨勢分析報告：按產品、應用、最終用途、地區和細分市場預測，2025 年至 2030 年

Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 170 Pages | 商品交期: 2-10個工作天內

價格

藥物輸送市場的成長與趨勢

根據 Grand View Research, Inc. 的新報告，全球藥物輸送設備市場預計到 2030 年將達到 6,674 億美元，2025 年至 2030 年期間的複合年成長率為 7.5%。

預計未來幾年癌症、神經系統疾病、糖尿病和其他感染疾病的發生率不斷上升將推動藥物傳輸裝置的採用。此外，眼科、神經病學、腫瘤學等各種應用領域的產品推出不斷增加預計將推動市場成長。此外，穿戴式藥物輸送設備在居家醫療環境中的日益普及也有望推動市場的發展。

水凝膠是突出的藥物傳遞載體之一，包括超分子水凝膠、DNA水凝膠、仿生水凝膠、多功能水凝膠和刺激反應水凝膠。這些先進的水凝膠用於多種應用，包括眼科、口腔、腸道、心臟疾病和癌症。類似地，脂質體、奈米粒子和膠束等其他載體也被開發用於各種應用。

市場的主要參與企業正在採用併購、合作和共同開發等各種策略來開發和改進各種應用的藥物輸送裝置。此外，最終用戶還與公司夥伴關係購買藥物輸送設備，用於培訓目的和研究。此外，市場參與企業正在簽訂分銷協議以擴大其產品的覆蓋範圍。因此，預計預測期內公司之間的合作將推動市場成長。

藥物輸送市場報告重點

  • 受氣喘治療需求的推動，吸入器領域將在 2024 年佔據 23.9% 的市場佔有率，引領市場。然而，傳統的定量吸入器對溫室氣體排放貢獻巨大。
  • 2024 年，糖尿病藥物輸送裝置領域佔據市場主導地位，佔有率為 21.1%。
  • 受外科手術和預防程序需求不斷成長的推動，預計到 2024 年醫院部門將佔據最大的市場佔有率佔有率，達到 29.0%。
  • 北美藥物輸送設備市場將主導全球市場，到 2024 年收入佔有率將達到 32.4%。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章藥物輸送裝置市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 藥物輸送裝置市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析

第4章 藥物輸送裝置市場：依產品分類的估算與趨勢分析

  • 細分儀表板
  • 藥物輸送裝置市場：產品差異分析
  • 藥物輸送裝置市場：產品展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 吸入器
  • 注射裝置
  • 植入
  • 局部配送系統
  • 口服給藥系統
  • 眼科輸送系統
  • 噴霧器
  • 經皮吸收貼片
  • 點滴幫浦

第5章藥物輸送裝置市場：按應用的估計和趨勢分析

  • 細分儀表板
  • 藥物輸送裝置市場：應用趨勢分析
  • 藥物輸送裝置市場：應用展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 腫瘤學
  • 感染疾病
  • 呼吸系統疾病
  • 糖尿病
  • 心血管疾病
  • 自體免疫疾病
  • 中樞神經系統疾病
  • 其他

第6章藥物輸送裝置市場：最終用途、估計與趨勢分析

  • 細分儀表板
  • 藥物輸送設備市場：最終用途差異分析
  • 藥物輸送設備市場：依最終用途分類的展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 醫院
  • 診斷中心
  • 門診手術中心/診所
  • 居家照護
  • 其他

第7章藥物輸送裝置市場：區域、估計與趨勢分析

  • 區域儀表板
  • 區域藥物輸送裝置市場波動分析
  • 藥物輸送裝置市場：按分銷管道和最終用途分類的區域評估和趨勢分析
  • 2018-2030年市場規模、預測及趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
    • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 市場參與企業分類
  • 主要企業簡介
    • Gerresheimer AG
    • WL Gore & Associates, Inc.
    • Abbott
    • Terumo Medical Corporation
    • Stryker
    • Medtronic
    • Boston Scientific Corporation
    • Novartis AG
    • Becton, Dickinson and Company
    • Teleflex Incorporated
Product Code: GVR-4-68038-435-2

Drug Delivery Devices Market Growth & Trends:

The global drug delivery devices market size is expected to reach USD 667.4 billion by 2030, registering a CAGR of 7.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing prevalence of cancer, neurological disorders, diabetes, and other infectious diseases is expected to drive the adoption of drug delivery devices in the coming years. In addition, increasing product launches for various applications such as ophthalmology, neurology, and oncology are also expected to propel the market growth. Growing adoption of wearable drug delivery devices for its usage in home-care settings is also expected to drive the market.

Hydrogel is one of the prominent drug delivery vehicles and includes supramolecular hydrogels, DNA hydrogels, bio-inspired hydrogels, multi-functional and stimuli-responsive hydrogels. These advanced hydrogels are used for various applications such as ophthalmic, oral, intestinal, cardiac illness, and cancer. Similarly, other vehicles such as liposomes, nanoparticles, and micelle are also being developed for various applications.

Key players present in the market are adopting various strategies such as mergers and acquisitions, partnership, and collaborations to develop and improve drug delivery devices for various applications. Moreover, end-users are also forming partnerships with companies to acquire drug delivery devices for training purpose and research studies. In addition, market players are also forming distribution agreement to expand the reach of their products. Therefore, alliances made by the players are expected to drive the market growth during the forecast period.

Drug Delivery Devices Market Report Highlights:

  • The inhalers segment leads the market with a share of 23.9% in 2024, driven by the demand for asthma treatment. However, conventional metered-dose inhalers contribute significantly to greenhouse gas emissions.
  • The drug delivery devices segment for diabetes dominated the market in 2024 with a share of 21.1%.
  • The hospitals segment held the largest market share in 2024 with a share of 29.0%, driven by the rising demand for surgical interventions and preventive procedures.
  • The North America drug delivery devices market dominated the overall global market and accounted for the 32.4% revenue share in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.21. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Drug Delivery Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing demand for novel drug delivery devices
      • 3.2.1.2. Increasing prevalence of chronic diseases
      • 3.2.1.3. Technological advancement in drug delivery devices
      • 3.2.1.4. Growing strategic alliances for drug delivery devices
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Challenges associated with various routes of drug delivery devices
  • 3.3. Drug Delivery Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Drug Delivery Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Drug Delivery Devices Market: Product Movement Analysis
  • 4.3. Drug Delivery Devices Market by Product Outlook (USD Billion)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Inhalers
    • 4.5.1. Inhalers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.5.1.1. Metered-dose inhalers (MDIs)
        • 4.5.1.1.1. Metered-dose inhalers (MDIs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.5.1.2. Dry powder inhalers (DPIs)
        • 4.5.1.2.1. Dry powder inhalers (DPIs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.5.1.3. Others
        • 4.5.1.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6. Injection Devices
    • 4.6.1. Injection Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.1.1. Prefilled Syringes
        • 4.6.1.1.1. Prefilled Syringes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.1.2. Auto-injectors
        • 4.6.1.2.1. Auto-injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.1.3. Pen Injectors
        • 4.6.1.3.1. Pen Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.1.4. Needle-free Injectors
        • 4.6.1.4.1. Needle-free Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.1.5. Wearable Injectors
        • 4.6.1.5.1. Wearable Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.7. Implants
    • 4.7.1. Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.7.1.1. Contraceptive Implants
        • 4.7.1.1.1. Contraceptive Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.7.1.2. Drug-eluting Stents
        • 4.7.1.2.1. Drug-eluting Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.7.1.3. Biodegradable Implants
        • 4.7.1.3.1. Biodegradable Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.8. Topical Delivery System
    • 4.8.1. Topical Delivery System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.8.1.1. Creams
        • 4.8.1.1.1. Creams Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.8.1.2. Gels
        • 4.8.1.2.1. Gels Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.8.1.3. Ointments
        • 4.8.1.3.1. Ointments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.9. Oral Delivery System
    • 4.9.1. Oral Delivery System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.9.1.1. Controlled-release Tablets and Capsules
        • 4.9.1.1.1. Controlled-release Tablets and Capsules Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.9.1.2. Buccal and Sublingual Tablets
        • 4.9.1.2.1. Buccal and Sublingual Tablets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.10. Occular Delivery System
    • 4.10.1. Occular Delivery System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.11. Nebulizers
    • 4.11.1. Nebulizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.12. Transdermal Patches
    • 4.12.1. Transdermal Patches Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.13. Infusion Pumps
    • 4.13.1. Infusion Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Drug Delivery Devices Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Drug Delivery Devices Market: Application Movement Analysis
  • 5.3. Drug Delivery Devices Market by Application Outlook (USD Billion)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Oncology
    • 5.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Infectious Diseases
    • 5.6.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. Respiratory Diseases
    • 5.7.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8. Diabetes
    • 5.8.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.9. Cardiovascular Diseases
    • 5.9.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.10. Autoimmune Diseases
    • 5.10.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.11. Central Nervous System Disorders
    • 5.11.1. Central Nervous System Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.12. Others
    • 5.12.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Drug Delivery Devices Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Drug Delivery Devices Market: End-use Movement Analysis
  • 6.3. Drug Delivery Devices Market by End-use Outlook (USD Billion)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Diagnostic Centers
    • 6.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Ambulatory Surgery Centers/Clinics
    • 6.7.1. Ambulatory Surgery Centers/Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8. Home Care Settings
    • 6.8.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.9. Others
    • 6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Drug Delivery Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Drug Delivery Devices Market Movement Analysis
  • 7.3. Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Distribution Channel & End-use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. North America
    • 7.5.1. North America Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.5. Europe
    • 7.5.6. Europe Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.7. UK
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. UK Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.8. Germany
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement scenario
      • 7.5.8.5. Germany Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.9. France
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement scenario
      • 7.5.9.5. France Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.10. Italy
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement scenario
      • 7.5.10.5. Italy Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.11. Spain
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement scenario
      • 7.5.11.5. Spain Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.12. Denmark
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement scenario
      • 7.5.12.5. Denmark Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.13. Sweden
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement scenario
      • 7.5.13.5. Sweden Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.14. Norway
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Competitive Scenario
      • 7.5.14.3. Regulatory Framework
      • 7.5.14.4. Reimbursement scenario
      • 7.5.14.5. Norway Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Japan Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. China Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. India Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. South Korea Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Australia Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Thailand Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.7. Latin America
    • 7.7.1. Latin America Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Brazil Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Argentina Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. South Africa Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Saudi Arabia Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. UAE Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Kuwait Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Gerresheimer AG
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. W. L. Gore & Associates, Inc.
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Abbott
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Terumo Medical Corporation
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Stryker
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Medtronic
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Boston Scientific Corporation
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Novartis AG
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Becton, Dickinson and Company
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Teleflex Incorporated
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. North America drug delivery devices market, by country, 2018 - 2030 (USD Billion)
  • Table 4. North America drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 5. North America drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 6. North America drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 7. U.S. drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 8. U.S. drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 9. U.S. drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 10. Canada drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 11. Canada drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 12. Canada drug delivery devices market, by end-use, (USD Billion) 2018 - 2030
  • Table 13. Mexico drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 14. Mexico drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 15. Mexico drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 16. Europe drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 17. Europe drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 18. Europe drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 19. Europe drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 20. Germany drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 21. Germany drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 22. Germany drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 23. U.K. drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 24. U.K. drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 25. U.K. drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 26. France drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 27. France drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 28. France drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 29. Italy drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 30. Italy drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 31. Italy drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 32. Spain drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 33. Spain drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 34. Spain drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 35. Denmark drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 36. Denmark drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 37. Denmark drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 38. Sweden drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 39. Sweden drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 40. Sweden drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 41. Norway drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 42. Norway drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 43. Norway drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 44. APAC drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 45. APAC drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 46. APAC drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 47. APAC drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 48. China drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 49. China drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 50. China drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 51. Japan drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 52. Japan drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 53. Japan drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 54. India drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 55. India drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 56. India drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 57. Thailand drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 58. Thailand drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 59. Thailand drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 60. South Korea drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 61. South Korea drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 62. South Korea drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 63. Australia drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 64. Australia drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 65. Australia drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 66. Latin America drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 67. Latin America drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 68. Latin America drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 69. Latin America drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 70. Brazil drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 71. Brazil drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 72. Brazil drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 73. Argentina drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 74. Argentina drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 75. Argentina drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 76. Middle East and Africa drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 77. Middle East and Africa drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 78. Middle East and Africa drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 79. Middle East and Africa drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 80. South Africa drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 81. South Africa drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 82. South Africa drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 83. Saudi Arabia drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 84. Saudi Arabia drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 85. Saudi Arabia drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 86. UAE drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 87. UAE drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 88. UAE drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 89. Kuwait drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 90. Kuwait drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 91. Kuwait drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Drug delivery devices market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Drug delivery devices market, Product outlook key takeaways (USD Billion)
  • Fig. 12 Drug delivery devices market Product movement analysis 2023 & 2030 (USD Billion)
  • Fig. 13 Inhalers market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 14 Metered-dose inhalers (MDIs) market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 15 Dry powder inhalers (DPIs) market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 16 Others market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 17 Injection devices market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 18 Prefilled syringes market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 19 Auto-injectors market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 20 Pen injectors market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 21 Needle-free injectors market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 22 Wearable injectors market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 23 Implants market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 24 Contraceptive implants market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 25 Drug-eluting stents market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 26 Biodegradable implants market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 27 Topical delivery system market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 28 Creams market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 29 Gels market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 30 Ointments market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 31 Oral delivery system market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 32 Controlled-release tablets and capsules market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 33 Buccal and sublingual tablets market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 34 Occular delivery system market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 35 Nebulizers market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 36 Transdermal patches market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 Infusion pumps market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 38 Drug delivery devices market, application outlook key takeaways (USD Billion)
  • Fig. 39 Drug delivery devices market application movement analysis 2023 & 2030 (USD Billion)
  • Fig. 40 Oncology market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 41 Infectious diseases market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 42 Respiratory diseases market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 43 Diabetes market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Cardiovascular diseases market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 45 Autoimmune diseases market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 46 Central nervous system disorders market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 Others market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 Drug delivery devices market, end use outlook key takeaways (USD Billion)
  • Fig. 49 Drug delivery devices market, end use movement analysis 2023 & 2030 (USD Billion)
  • Fig. 50 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 51 Diagnostic centers market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 Ambulatory surgery centers/clinics market, application outlook key takeaways (USD Billion)
  • Fig. 53 Home care settings market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 Others market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 55 Drug delivery devices market: Regional key takeaways (USD Billion)
  • Fig. 56 Drug delivery devices market regional outlook, 2023 & 2030 (USD Billion)
  • Fig. 57 North America drug delivery devices estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 58 US drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 Canada drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 60 Mexico drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Europe drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 62 UK drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 Germany drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 64 France drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 65 Spain drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 66 Italy drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 67 Sweden drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 68 Norway drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 69 Denmark drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 70 Asia Pacific drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 71 China drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 72 Japan drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 73 India drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 74 South Korea drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 75 Australia drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 76 Thailand drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 77 Latin America drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 78 Brazil drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 79 Argentina drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 80 Middle East and Africa drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 81 South Africa drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 82 Saudi Arabia drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 83 UAE drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 84 Kuwait drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 85 List of key emerging company's/distribution channel disruptors/innovators